LIFEVEST WCD 4000 SYSTEM
Report
- Report Number
- 3008642652-2016-06926
- Event Type
- Death
- Date Received
- September 27, 2016
- Date of Event
- August 22, 2016
- Report Date
- September 26, 2016
- Manufacturer
- ZOLL MANUFACTURING CORPORATION
- Product Code
- MVK
- PMA / PMN Number
- P010030
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER
Narratives
MONITOR SN (B)(4) AND ELECTRODE BELT SN (B)(4) HAVE NOT YET BEEN RETURNED FOR INVESTIGATION. A REVIEW OF DOWNLOAD DATA DOES NOT SUGGEST ANY DEVICE MALFUNCTION CAUSING OR CONTRIBUTING TO THE EVENT. A CAUSE AND EFFECT ANALYSIS WAS CONDUCTED USING ALL OF THE AVAILABLE INFORMATION WHICH INCLUDES THE INCIDENT REPORT, DEVICE EVALUATION, SOFTWARE FLAG FILES, AND ECG STRIPS. THE PRIMARY CAUSE OF THE INAPPROPRIATE SHOCK WAS IMPROPER RESPONSE BUTTON USE BY THE PATIENT DURING THE FALSE DETECTION, PRIOR TO SHOCK DELIVERY. THE ECG ANALYSIS, CONDUCTED BY TRAINED ECG TECHNICIANS, IDENTIFIED THE PRIMARY CAUSE OF THE FALSE DETECTION WAS THE PRESENCE OF NSVT. INAPPROPRIATE DEFIBRILLATIONS ARE AN ANTICIPATED RISK ASSOCIATED WITH THE USE OF THE LIFEVEST. PATIENTS ARE INSTRUCTED THROUGH ALARMS, VOICE MESSAGES, IFU, AND TRAINING TO PRESS THE RESPONSE BUTTONS TO PREVENT AN INAPPROPRIATE DEFIBRILLATION. THE CURRENT COMMERCIAL INAPPROPRIATE DEFIBRILLATION RATE IS CONSISTENT WITH THE OBSERVED RATE DURING THE PIVOTAL CLINICAL TRIAL G960083 (0.69% PER PATIENT-MONTH WITH 90% CONFIDENCE). A SUMMARY OF THE SAFETY AND EFFECTIVENESS DATA (SSED), INCLUDING THE INAPPROPRIATE DEFIBRILLATION SAFETY OBJECTIVE SUPPORTING FDA'S APPROVAL OF THE LIFEVEST, CAN BE FOUND AT <HTTP://WWW.ACCESSDATA.FDA.GOV/CDRH_DOCS/PDF/P010030S056B.PDF>. THE LIFEVEST DETECTION ALGORITHM COMPLIES WITH IEC 60601-2-4 PERFORMANCE REQUIREMENTS FOR SENSITIVITY AND SPECIFICITY.
A US DISTRIBUTOR CONTACTED ZOLL TO REPORT THAT THE PATIENT PASSED AWAY ON (B)(6) 2016. A REVIEW OF DOWNLOAD DATA REVEALED THAT THE PATIENT WAS TREATED AT 06:50:29 ON (B)(6) 2016. THE RHYTHM AT THE TIME OF THE TREATMENT WAS AN INTERMITTENT IDIOVENTRICULAR RHYTHM WITH NSVT. THE PRESENCE OF NSVT CONTRIBUTED TO THE FALSE DETECTION. THE PATIENT REMAINED IN AN IDIOVENTRICULAR RHYTHM AFTER THE TREATMENT.. THE RESPONSE BUTTONS WERE PRESSED BEFORE THE TREATMENT, BUT NOT IN THE DETECTION SEQUENCE THAT LED TO THE SHOCK. THE LIFEVEST WAS SHUTDOWN AT 07:09:05. THE PATIENT REPORTEDLY PASSED AWAY AT 7:10AM.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 632900 | LIFEVEST WCD 4000 SYSTEM | WEARABLE CARDIOVERTER DEFIBRILLATOR | MVK | ZOLL MANUFACTURING CORPORATION | WCD 4000 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Death |